Erin A Vogel, Katelyn F Romm, D J McMaughan, Cassidy R LoParco, Palash Bhanot, Patricia A Cavazos-Rehg, Hannah Szlyk, Erin Kasson, Carla J Berg
{"title":"神经分化、少数民族压力和烟草使用在美国性和性别少数的年轻人样本中。","authors":"Erin A Vogel, Katelyn F Romm, D J McMaughan, Cassidy R LoParco, Palash Bhanot, Patricia A Cavazos-Rehg, Hannah Szlyk, Erin Kasson, Carla J Berg","doi":"10.1177/29767342251338946","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Minority stress is related to tobacco use inequities among sexual and gender minoritized young adults (SGM YAs). Neurodivergent SGM YAs may experience greater minority stress (from dual-minoritized identities) and tobacco use.</p><p><strong>Methods: </strong>A 2023 survey assessed neurodivergence (defined as attention-deficit hyperactivity disorder [ADHD] or a learning-related condition), minority stressors (mental health symptoms, internalized SGM stigma, SGM community connectedness), and tobacco use (past-month cigarette, e-cigarette, any tobacco product use; number of products used) among SGM YAs (aged 18-34) in the United States. Multivariable regression examined associations of neurodivergence with minority stressors and tobacco use.</p><p><strong>Results: </strong>Among SGM YAs (N = 1115; <i>M</i><sub>age</sub> = 25.34 [SD = 4.84]; 65.2% bisexual+, 29.5% monosexual, 4.8% another identity; 52.2% cisgender women, 29.8% cisgender men, 17.2% gender minority), 36.1% reported neurodivergence, 23.4% reported current cigarette use, 30.0% e-cigarette use, and 40.4% any tobacco use. On average, participants reporting current tobacco use used 2 to 3 products (<i>M</i> = 2.06 [SD = 1.25]). Neurodivergence was associated with higher odds of experiencing mental health symptoms (aOR = 1.53, 95% CI [1.19-1.95]), cigarette use (aOR = 1.48, 95% CI [1.07-2.05]), e-cigarette use (aOR = 1.80, 95% CI [1.35-2.42]), and any tobacco product use (aOR = 1.63, 95% CI [1.23-2.17]). Mental health symptoms were associated with cigarette (aOR = 1.63, 95% CI [1.19-2.25]), e-cigarette (aOR = 1.58, 95% CI [1.19-2.11]), and any tobacco product use (aOR = 1.48, 95% CI [1.13-1.96]).</p><p><strong>Conclusions: </strong>Neurodivergent SGM YAs (vs those without ADHD or learning-related conditions) may have greater risk for mental health symptoms and related tobacco use, underscoring the need for appropriate and culturally competent mental healthcare to reduce tobacco use.</p>","PeriodicalId":516535,"journal":{"name":"Substance use & addiction journal","volume":" ","pages":"939-949"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Neurodivergence, Minority Stress, and Tobacco Use in a Sample of US Sexual and Gender Minoritized Young Adults.\",\"authors\":\"Erin A Vogel, Katelyn F Romm, D J McMaughan, Cassidy R LoParco, Palash Bhanot, Patricia A Cavazos-Rehg, Hannah Szlyk, Erin Kasson, Carla J Berg\",\"doi\":\"10.1177/29767342251338946\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Minority stress is related to tobacco use inequities among sexual and gender minoritized young adults (SGM YAs). Neurodivergent SGM YAs may experience greater minority stress (from dual-minoritized identities) and tobacco use.</p><p><strong>Methods: </strong>A 2023 survey assessed neurodivergence (defined as attention-deficit hyperactivity disorder [ADHD] or a learning-related condition), minority stressors (mental health symptoms, internalized SGM stigma, SGM community connectedness), and tobacco use (past-month cigarette, e-cigarette, any tobacco product use; number of products used) among SGM YAs (aged 18-34) in the United States. Multivariable regression examined associations of neurodivergence with minority stressors and tobacco use.</p><p><strong>Results: </strong>Among SGM YAs (N = 1115; <i>M</i><sub>age</sub> = 25.34 [SD = 4.84]; 65.2% bisexual+, 29.5% monosexual, 4.8% another identity; 52.2% cisgender women, 29.8% cisgender men, 17.2% gender minority), 36.1% reported neurodivergence, 23.4% reported current cigarette use, 30.0% e-cigarette use, and 40.4% any tobacco use. On average, participants reporting current tobacco use used 2 to 3 products (<i>M</i> = 2.06 [SD = 1.25]). Neurodivergence was associated with higher odds of experiencing mental health symptoms (aOR = 1.53, 95% CI [1.19-1.95]), cigarette use (aOR = 1.48, 95% CI [1.07-2.05]), e-cigarette use (aOR = 1.80, 95% CI [1.35-2.42]), and any tobacco product use (aOR = 1.63, 95% CI [1.23-2.17]). Mental health symptoms were associated with cigarette (aOR = 1.63, 95% CI [1.19-2.25]), e-cigarette (aOR = 1.58, 95% CI [1.19-2.11]), and any tobacco product use (aOR = 1.48, 95% CI [1.13-1.96]).</p><p><strong>Conclusions: </strong>Neurodivergent SGM YAs (vs those without ADHD or learning-related conditions) may have greater risk for mental health symptoms and related tobacco use, underscoring the need for appropriate and culturally competent mental healthcare to reduce tobacco use.</p>\",\"PeriodicalId\":516535,\"journal\":{\"name\":\"Substance use & addiction journal\",\"volume\":\" \",\"pages\":\"939-949\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Substance use & addiction journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/29767342251338946\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance use & addiction journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/29767342251338946","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/27 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Neurodivergence, Minority Stress, and Tobacco Use in a Sample of US Sexual and Gender Minoritized Young Adults.
Background: Minority stress is related to tobacco use inequities among sexual and gender minoritized young adults (SGM YAs). Neurodivergent SGM YAs may experience greater minority stress (from dual-minoritized identities) and tobacco use.
Methods: A 2023 survey assessed neurodivergence (defined as attention-deficit hyperactivity disorder [ADHD] or a learning-related condition), minority stressors (mental health symptoms, internalized SGM stigma, SGM community connectedness), and tobacco use (past-month cigarette, e-cigarette, any tobacco product use; number of products used) among SGM YAs (aged 18-34) in the United States. Multivariable regression examined associations of neurodivergence with minority stressors and tobacco use.
Results: Among SGM YAs (N = 1115; Mage = 25.34 [SD = 4.84]; 65.2% bisexual+, 29.5% monosexual, 4.8% another identity; 52.2% cisgender women, 29.8% cisgender men, 17.2% gender minority), 36.1% reported neurodivergence, 23.4% reported current cigarette use, 30.0% e-cigarette use, and 40.4% any tobacco use. On average, participants reporting current tobacco use used 2 to 3 products (M = 2.06 [SD = 1.25]). Neurodivergence was associated with higher odds of experiencing mental health symptoms (aOR = 1.53, 95% CI [1.19-1.95]), cigarette use (aOR = 1.48, 95% CI [1.07-2.05]), e-cigarette use (aOR = 1.80, 95% CI [1.35-2.42]), and any tobacco product use (aOR = 1.63, 95% CI [1.23-2.17]). Mental health symptoms were associated with cigarette (aOR = 1.63, 95% CI [1.19-2.25]), e-cigarette (aOR = 1.58, 95% CI [1.19-2.11]), and any tobacco product use (aOR = 1.48, 95% CI [1.13-1.96]).
Conclusions: Neurodivergent SGM YAs (vs those without ADHD or learning-related conditions) may have greater risk for mental health symptoms and related tobacco use, underscoring the need for appropriate and culturally competent mental healthcare to reduce tobacco use.